APREA
Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea Therapeutics was established in 2003 in Stockholms Lan, Sweden by Klas Wiman and Galina Selivanova.
APREA
Industry:
Biotechnology Health Care Medical Personal Health Pharmaceutical
Founded:
2003-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.aprea.com
Total Employee:
1+
Status:
Active
Contact:
+460850884504
Email Addresses:
[email protected]
Total Funding:
136.37 M USD
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Content Delivery Network JsDelivr Nginx COVID-19 Gravity Forms Akamai Hosted Nginx 1.10 Formidable Pro Form
Similar Organizations
AEON Biopharma
AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Cellectis
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Medivir
Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases.
Novartis
Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-16 | Atrin Pharmaceuticals | Atrin Pharmaceuticals acquired by Aprea | N/A |
Investors List
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Aprea
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Aprea
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - Aprea
Exome Asset Management
Exome Asset Management investment in Post-IPO Equity - Aprea
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Aprea
National Cancer Institute
National Cancer Institute investment in Grant - Aprea
Keiretsu Capital
Keiretsu Capital investment in Post-IPO Equity - Aprea
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Aprea
Redmile Group
Redmile Group investment in Series C - Aprea
Karolinska
Karolinska investment in Series C - Aprea
Official Site Inspections
http://www.aprea.com Semrush global rank: 5.01 M Semrush visits lastest month: 1.65 K
- Host name: 104.21.90.229
- IP address: 104.21.90.229
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aprea"
Aprea Therapeutics Board of Directors
Meet the Aprea Therapeutics board of directors. Their exceptional qualifications and expertise have fueled our growth as leaders in DDR-targeted therapeutics. ... Vice President and Head of Drug Regulatory Affairs for Novartis Oncology, …See details»
Aprea - Crunchbase Company Profile & Funding
Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The …See details»
Aprea Therapeutics Management Team
John joined Aprea in January 2023 from Windtree Therapeutics where he served as Senior Vice President and Chief Financial Officer since 2020. He brings more than 30 years of financial leadership experience in the pharmaceutical, …See details»
Aprea Therapeutics | DDR-Targeted Therapy
Aprea leverages these concepts by developing small molecule inhibitors that are synthetically …See details»
Aprea Therapeutics, Inc. - Drug pipelines, Patents, Clinical
DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. …See details»
Aprea - VentureRadar
Aprea Therapeutics USA Privately Held Aprea Therapeutics is a Stockholm, Sweden and …See details»
Aprea Therapeutics, Inc. (APRE) Company Profile & Overview
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing …See details»
Aprea Therapeutics Company Profile - Office Locations ... - Craft
Sep 6, 2024 Aprea Therapeutics is a pharmaceutical development company that is engaged …See details»
Aprea - Contacts, Employees, Board Members, Advisors & Alumni
Aprea has 5 current employee profiles, including President and chief executive officer Christian …See details»
Aprea - Funding, Financials, Valuation & Investors - Crunchbase
Aprea is registered under the ticker NASDAQ:APRE . Their stock opened with $15.00 in its Oct …See details»
Aprea Therapeutics Provides Corporate Update and Announces …
DOYLESTOWN, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. …See details»
Aprea Therapeutics | Leaders in DDR-Targeted Solutions
Aprea Therapeutics acquired privately held Atrin Pharmaceuticals in May 2022. Aprea has …See details»
APREA Board of Directors - aprea.asia
APREA Board of Directors. The Board is responsible for general oversight of management and …See details»
Aprea Therapeutics Announces Acquisition of Atrin …
May 16, 2022 About Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. is a biopharmaceutical …See details»
Aprea Therapeutics Reports Third Quarter 2022 Financial Results …
Sep 30, 2022 Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in …See details»
Aprea Therapeutics, Inc. (APRE) - Yahoo Finance Canada
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing …See details»
Aprea Therapeutics Announces Submission of IND Application for …
Feb 6, 2024 Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company …See details»
Aprea Therapeutics, Inc. (APRE) - Stock Analysis
Nov 15, 2024 Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses …See details»
Aprea Therapeutics Pipeline
ATR Program: ATRN-119. The ataxia telangiectasia and Rad3-related (ATR) kinase is a …See details»
Clinical Trials Put Discovery Into Action - Aprea Therapeutics
ACESOT-1051 – WEE1 Clinical Program: APR-1051. ACESOT-1051 is an ongoing first-in …See details»